David DiLoreto
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Retina | 12 | 1994 | 60 |
Why?
| Retinal Degeneration | 7 | 1994 | 16 |
Why?
| Fetal Tissue Transplantation | 7 | 1994 | 12 |
Why?
| Retinal Vasculitis | 2 | 2003 | 3 |
Why?
| Retinal Artery | 2 | 2003 | 12 |
Why?
| Aging | 6 | 1994 | 275 |
Why?
| Photoreceptor Cells | 7 | 1994 | 13 |
Why?
| Retinal Diseases | 3 | 1994 | 22 |
Why?
| Fluorescein Angiography | 6 | 1994 | 19 |
Why?
| Pigment Epithelium of Eye | 3 | 1996 | 9 |
Why?
| Blindness | 1 | 2009 | 22 |
Why?
| Eosinophilia | 1 | 2009 | 24 |
Why?
| Visual Acuity | 4 | 1990 | 46 |
Why?
| Retinal Necrosis Syndrome, Acute | 1 | 2007 | 3 |
Why?
| Foscarnet | 1 | 2007 | 4 |
Why?
| Herpesvirus 2, Human | 1 | 2007 | 7 |
Why?
| Rats, Inbred F344 | 11 | 1993 | 80 |
Why?
| Behavior, Animal | 4 | 1995 | 77 |
Why?
| Herpes Simplex | 1 | 2007 | 31 |
Why?
| Bruch Membrane | 1 | 2006 | 1 |
Why?
| Choroid | 1 | 2006 | 6 |
Why?
| Fundus Oculi | 5 | 1994 | 15 |
Why?
| Antiviral Agents | 1 | 2007 | 91 |
Why?
| Rats | 17 | 1993 | 530 |
Why?
| Choroidal Neovascularization | 1 | 2004 | 2 |
Why?
| Retinal Vein Occlusion | 1 | 2004 | 3 |
Why?
| Acquired Immunodeficiency Syndrome | 2 | 2001 | 85 |
Why?
| Ophthalmology | 1 | 2003 | 13 |
Why?
| Retinitis | 1 | 2003 | 4 |
Why?
| Aneurysm | 1 | 2003 | 20 |
Why?
| Cell Transplantation | 3 | 1993 | 20 |
Why?
| Biomedical Research | 1 | 2003 | 87 |
Why?
| Rats, Mutant Strains | 4 | 1995 | 14 |
Why?
| Cell Survival | 5 | 1993 | 229 |
Why?
| Tuberculoma | 1 | 2001 | 4 |
Why?
| Tuberculosis, Ocular | 1 | 2001 | 2 |
Why?
| Choroid Diseases | 1 | 2001 | 2 |
Why?
| Vision, Ocular | 3 | 1995 | 34 |
Why?
| Outcome Assessment (Health Care) | 1 | 2003 | 163 |
Why?
| Animals | 22 | 1990 | 1031 |
Why?
| Tissue Preservation | 2 | 1996 | 16 |
Why?
| Coated Materials, Biocompatible | 1 | 1999 | 15 |
Why?
| Gold | 1 | 1999 | 17 |
Why?
| Eyelid Diseases | 1 | 1999 | 11 |
Why?
| Eyelids | 1 | 1999 | 15 |
Why?
| Retinitis Pigmentosa | 1 | 1999 | 8 |
Why?
| Prosthesis Implantation | 1 | 1999 | 23 |
Why?
| Prostheses and Implants | 2 | 1995 | 47 |
Why?
| Photography | 2 | 1994 | 27 |
Why?
| Fluorescein | 1 | 1997 | 17 |
Why?
| Cyclosporine | 3 | 1994 | 45 |
Why?
| Lacrimal Apparatus | 1 | 1997 | 10 |
Why?
| Humans | 24 | 1987 | 1856 |
Why?
| Cytomegalovirus Infections | 2 | 1994 | 39 |
Why?
| Drug Therapy, Combination | 2 | 2007 | 189 |
Why?
| Culture Media, Serum-Free | 1 | 1996 | 32 |
Why?
| Growth Substances | 1 | 1997 | 51 |
Why?
| Maze Learning | 1 | 1996 | 10 |
Why?
| Eye, Artificial | 1 | 1995 | 2 |
Why?
| Silicone Elastomers | 1 | 1995 | 9 |
Why?
| Contrast Media | 1 | 1997 | 116 |
Why?
| Male | 14 | 1987 | 1553 |
Why?
| Orbit | 1 | 1995 | 28 |
Why?
| Antiretroviral Therapy, Highly Active | 2 | 2001 | 27 |
Why?
| Oculomotor Muscles | 2 | 1990 | 19 |
Why?
| Neuroglia | 1 | 1995 | 49 |
Why?
| Transplantation, Heterologous | 6 | 1993 | 57 |
Why?
| Nerve Tissue Proteins | 1 | 1997 | 128 |
Why?
| Disease Models, Animal | 5 | 1993 | 349 |
Why?
| Prednisone | 2 | 1990 | 80 |
Why?
| Cysticercus | 1 | 1990 | 1 |
Why?
| Cysticercosis | 1 | 1990 | 4 |
Why?
| Dependovirus | 1 | 2011 | 29 |
Why?
| Microglia | 1 | 2011 | 29 |
Why?
| Transduction, Genetic | 1 | 2011 | 65 |
Why?
| Retinal Ganglion Cells | 1 | 2011 | 18 |
Why?
| Vitreous Body | 2 | 2003 | 14 |
Why?
| Graves Disease | 1 | 1990 | 11 |
Why?
| Green Fluorescent Proteins | 1 | 2011 | 105 |
Why?
| Female | 9 | 1990 | 1643 |
Why?
| Vision, Monocular | 1 | 2009 | 8 |
Why?
| RNA, Messenger | 1 | 1997 | 394 |
Why?
| Vasoconstriction | 1 | 2009 | 37 |
Why?
| Arterioles | 1 | 2009 | 14 |
Why?
| Genetic Vectors | 1 | 2011 | 139 |
Why?
| Eyelid Neoplasms | 1 | 1987 | 9 |
Why?
| Vitreous Hemorrhage | 1 | 2007 | 3 |
Why?
| Vitrectomy | 1 | 2007 | 10 |
Why?
| Acyclovir | 1 | 2007 | 28 |
Why?
| Osteosarcoma | 1 | 1987 | 31 |
Why?
| Glucocorticoids | 1 | 2009 | 107 |
Why?
| Injections, Intravenous | 1 | 2007 | 105 |
Why?
| Retinal Vessels | 1 | 2007 | 17 |
Why?
| Phagosomes | 1 | 2006 | 1 |
Why?
| Cell Count | 2 | 1997 | 163 |
Why?
| Lipofuscin | 1 | 2006 | 4 |
Why?
| Neovascularization, Pathologic | 1 | 2007 | 64 |
Why?
| Middle Aged | 3 | 1997 | 1161 |
Why?
| Rabbits | 2 | 1995 | 252 |
Why?
| Anticoagulants | 1 | 2009 | 88 |
Why?
| Microscopy, Electron | 3 | 1993 | 178 |
Why?
| Ultrasonography | 1 | 2007 | 89 |
Why?
| Retinal Hemorrhage | 1 | 2004 | 8 |
Why?
| Macular Edema | 1 | 2004 | 6 |
Why?
| Nerve Growth Factors | 2 | 1994 | 43 |
Why?
| Adult | 6 | 1987 | 1317 |
Why?
| Porphyrins | 1 | 2004 | 14 |
Why?
| Retinoblastoma | 2 | 1993 | 11 |
Why?
| Bias (Epidemiology) | 1 | 2003 | 35 |
Why?
| Photosensitizing Agents | 1 | 2004 | 7 |
Why?
| Glaucoma Drainage Implants | 1 | 2003 | 1 |
Why?
| Glaucoma, Open-Angle | 1 | 2003 | 6 |
Why?
| Photochemotherapy | 1 | 2004 | 18 |
Why?
| Eye Infections, Bacterial | 1 | 2003 | 8 |
Why?
| Endophthalmitis | 1 | 2003 | 9 |
Why?
| Publishing | 1 | 2003 | 30 |
Why?
| Regional Blood Flow | 1 | 2003 | 105 |
Why?
| Surgical Wound Infection | 1 | 2003 | 41 |
Why?
| Periodicals as Topic | 1 | 2003 | 41 |
Why?
| Pneumococcal Infections | 1 | 2003 | 31 |
Why?
| Child | 2 | 1990 | 749 |
Why?
| Eye Enucleation | 2 | 1995 | 10 |
Why?
| Antitubercular Agents | 1 | 2001 | 5 |
Why?
| Pregnancy | 2 | 1996 | 455 |
Why?
| Aged | 4 | 1990 | 988 |
Why?
| Mice | 4 | 1994 | 623 |
Why?
| Visual Fields | 2 | 1988 | 22 |
Why?
| Polyurethanes | 1 | 1999 | 5 |
Why?
| Microscopy, Electron, Scanning | 1 | 1999 | 69 |
Why?
| Polytetrafluoroethylene | 1 | 1999 | 23 |
Why?
| Postoperative Period | 1 | 1999 | 63 |
Why?
| Safety | 1 | 1999 | 80 |
Why?
| Glial Fibrillary Acidic Protein | 2 | 1993 | 37 |
Why?
| Escape Reaction | 1 | 1998 | 7 |
Why?
| Sensory Thresholds | 1 | 1998 | 25 |
Why?
| Trypan Blue | 1 | 1997 | 4 |
Why?
| Ophthalmoscopy | 1 | 1997 | 17 |
Why?
| Longitudinal Studies | 1 | 1999 | 195 |
Why?
| Coloring Agents | 1 | 1997 | 42 |
Why?
| Electrophoresis, Agar Gel | 1 | 1997 | 27 |
Why?
| Tissue Transplantation | 1 | 1997 | 6 |
Why?
| Receptors, Growth Factor | 1 | 1997 | 23 |
Why?
| Mice, SCID | 2 | 1994 | 61 |
Why?
| Chondroitin Sulfates | 1 | 1996 | 13 |
Why?
| Dextrans | 1 | 1996 | 36 |
Why?
| Neoplasm Transplantation | 2 | 1993 | 67 |
Why?
| Gentamicins | 1 | 1996 | 32 |
Why?
| Complex Mixtures | 1 | 1996 | 8 |
Why?
| Lighting | 1 | 1996 | 14 |
Why?
| Histocytochemistry | 1 | 1996 | 65 |
Why?
| Conjunctiva | 1 | 1995 | 19 |
Why?
| Cohort Studies | 1 | 1999 | 332 |
Why?
| Reflex, Pupillary | 1 | 1995 | 2 |
Why?
| Prosthesis Design | 1 | 1995 | 44 |
Why?
| Foreign-Body Migration | 1 | 1995 | 20 |
Why?
| Electroretinography | 1 | 1995 | 11 |
Why?
| DNA Primers | 1 | 1997 | 208 |
Why?
| Immunoblotting | 1 | 1995 | 119 |
Why?
| Photic Stimulation | 1 | 1996 | 58 |
Why?
| Biocompatible Materials | 1 | 1995 | 32 |
Why?
| Biological Markers | 1 | 1997 | 262 |
Why?
| Startle Reaction | 1 | 1995 | 10 |
Why?
| Aged, 80 and over | 2 | 1997 | 599 |
Why?
| Eye Movements | 1 | 1995 | 29 |
Why?
| Polymerase Chain Reaction | 1 | 1997 | 279 |
Why?
| Carbocyanines | 1 | 1994 | 13 |
Why?
| Mice, Transgenic | 1 | 1997 | 209 |
Why?
| Serpins | 1 | 1994 | 14 |
Why?
| Brain Tissue Transplantation | 1 | 1994 | 12 |
Why?
| Eye Neoplasms | 1 | 1993 | 17 |
Why?
| Follow-Up Studies | 1 | 1999 | 553 |
Why?
| Species Specificity | 1 | 1994 | 186 |
Why?
| Sex Characteristics | 1 | 1994 | 85 |
Why?
| Fluorescent Dyes | 1 | 1994 | 115 |
Why?
| Receptors, AMPA | 1 | 1993 | 17 |
Why?
| Virus Replication | 1 | 1994 | 90 |
Why?
| AIDS Dementia Complex | 1 | 1993 | 24 |
Why?
| Immunohistochemistry | 1 | 1995 | 355 |
Why?
| Synapsins | 1 | 2011 | 5 |
Why?
| Intravitreal Injections | 1 | 2011 | 6 |
Why?
| Macaca | 1 | 2011 | 34 |
Why?
| Orbital Diseases | 1 | 1990 | 18 |
Why?
| Rats, Sprague-Dawley | 1 | 1994 | 257 |
Why?
| Eye Diseases | 1 | 1990 | 24 |
Why?
| Connexins | 1 | 2011 | 18 |
Why?
| Postoperative Complications | 1 | 1995 | 305 |
Why?
| Cataract Extraction | 1 | 1990 | 12 |
Why?
| Genes, Reporter | 1 | 2011 | 111 |
Why?
| Intraocular Pressure | 1 | 1990 | 22 |
Why?
| Hyaluronic Acid | 1 | 1990 | 23 |
Why?
| Proteins | 1 | 1994 | 192 |
Why?
| Iodine Radioisotopes | 1 | 1990 | 64 |
Why?
| Microscopy, Confocal | 1 | 2011 | 105 |
Why?
| Axons | 1 | 2011 | 66 |
Why?
| Actins | 1 | 2011 | 112 |
Why?
| Papilledema | 1 | 1988 | 3 |
Why?
| Time Factors | 1 | 1995 | 896 |
Why?
| Amputation | 1 | 1987 | 17 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 1993 | 210 |
Why?
| Sinusitis | 1 | 1988 | 22 |
Why?
| Diagnosis, Differential | 1 | 1990 | 402 |
Why?
| HIV-1 | 1 | 1994 | 93 |
Why?
| Leg | 1 | 1987 | 75 |
Why?
| Cocaine | 1 | 1988 | 33 |
Why?
| Gene Expression | 1 | 2011 | 291 |
Why?
| Osteolysis | 1 | 1988 | 18 |
Why?
| HIV Infections | 1 | 1994 | 136 |
Why?
| Combined Modality Therapy | 1 | 1987 | 219 |
Why?
| Substance-Related Disorders | 1 | 1988 | 96 |
Why?
| Neoplasm Recurrence, Local | 1 | 1987 | 118 |
Why?
| Neurons | 1 | 1993 | 195 |
Why?
| Light | 2 | 1995 | 64 |
Why?
| Lung Neoplasms | 1 | 1987 | 159 |
Why?
| Aqueous Humor | 1 | 2003 | 9 |
Why?
| Device Removal | 1 | 2003 | 24 |
Why?
| Streptococcus pneumoniae | 1 | 2003 | 38 |
Why?
| Tumor Cells, Cultured | 2 | 1993 | 233 |
Why?
| Gestational Age | 1 | 1996 | 114 |
Why?
| Dose-Response Relationship, Radiation | 1 | 1995 | 85 |
Why?
| Fetus | 1 | 1996 | 105 |
Why?
| Rats, Nude | 1 | 1994 | 3 |
Why?
| Transplantation, Heterotopic | 1 | 1994 | 3 |
Why?
| Graft Survival | 1 | 1995 | 74 |
Why?
| Anterior Chamber | 1 | 1994 | 10 |
Why?
| Rats, Inbred Lew | 1 | 1994 | 17 |
Why?
| Thiolester Hydrolases | 1 | 1993 | 5 |
Why?
| Ubiquitin Thiolesterase | 1 | 1993 | 7 |
Why?
| Immunosuppressive Agents | 1 | 1996 | 102 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 1993 | 29 |
Why?
| Eye Proteins | 1 | 1994 | 26 |
Why?
| Reference Values | 1 | 1995 | 278 |
Why?
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1993 | 8 |
Why?
| Dizocilpine Maleate | 1 | 1993 | 10 |
Why?
| Immunoenzyme Techniques | 1 | 1993 | 125 |
Why?
| Blood-Brain Barrier | 1 | 1994 | 63 |
Why?
| Neoplasm Invasiveness | 1 | 1993 | 105 |
Why?
| Monocytes | 1 | 1994 | 124 |
Why?
| Cell Nucleus | 1 | 1995 | 169 |
Why?
| Recombinant Proteins | 1 | 1994 | 290 |
Why?
| Drainage | 1 | 1990 | 50 |
Why?
| Lenses, Intraocular | 1 | 1990 | 13 |
Why?
| Optic Disk | 1 | 1988 | 6 |
Why?
| Hyperemia | 1 | 1988 | 18 |
Why?
| Administration, Intranasal | 1 | 1988 | 25 |
Why?
| Double-Blind Method | 1 | 1990 | 274 |
Why?
| Randomized Controlled Trials as Topic | 1 | 1990 | 176 |
Why?
| Cell Differentiation | 1 | 1994 | 262 |
Why?
| Prognosis | 1 | 1990 | 388 |
Why?
| Cells, Cultured | 1 | 1993 | 447 |
Why?
| Prospective Studies | 1 | 1990 | 545 |
Why?
|
|
DiLoreto's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
